These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10606110)

  • 1. Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris.
    Rabah MM; Premmereur J; Graham M; Fareed J; Hoppensteadt DA; Grines LL; Grines CL
    Am J Cardiol; 1999 Dec; 84(12):1391-5. PubMed ID: 10606110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention.
    Díez JG; Medina HM; Cheong BY; O'Meallie L; Ferguson JJ
    Tex Heart Inst J; 2009; 36(2):98-103. PubMed ID: 19436801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
    Montalescot G; White HD; Gallo R; Cohen M; Steg PG; Aylward PE; Bode C; Chiariello M; King SB; Harrington RA; Desmet WJ; Macaya C; Steinhubl SR;
    N Engl J Med; 2006 Sep; 355(10):1006-17. PubMed ID: 16957147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban (the ACTION Trial).
    Madan M; Radhakrishnan S; Reis M; Paradiso-Hardy FL; Godin-Edgecombe M; Sparling C; Phillips AM; Shanmugasegaram S; Fort S; Naqvi SZ; Cohen EA
    Am J Cardiol; 2005 Jun; 95(11):1295-301. PubMed ID: 15904632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial.
    Montalescot G; Gallo R; White HD; Cohen M; Steg PG; Aylward PE; Bode C; Chiariello M; King SB; Harrington RA; Desmet WJ; Macaya C; Steinhubl SR;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1083-91. PubMed ID: 19926048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention.
    Choussat R; Montalescot G; Collet JP; Vicaut E; Ankri A; Gallois V; Drobinski G; Sotirov I; Thomas D
    J Am Coll Cardiol; 2002 Dec; 40(11):1943-50. PubMed ID: 12475453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial.
    Montalescot G; Zeymer U; Silvain J; Boulanger B; Cohen M; Goldstein P; Ecollan P; Combes X; Huber K; Pollack C; Bénezet JF; Stibbe O; Filippi E; Teiger E; Cayla G; Elhadad S; Adnet F; Chouihed T; Gallula S; Greffet A; Aout M; Collet JP; Vicaut E;
    Lancet; 2011 Aug; 378(9792):693-703. PubMed ID: 21856483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous enoxaparin versus unfractionated heparin in unselected patients undergoing percutaneous coronary interventions: the Zurich enoxaparin versus unfractionated heparin in PCI study (ZEUS).
    Bertel O; Ramsay D; Wettstein T; Kurz DJ; Stettler I; Straumann E; Frielingsdorf J; Maurer D; Naegeli B
    EuroIntervention; 2010 Aug; 6(3):407-12. PubMed ID: 20884422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.
    Ferguson JJ; Califf RM; Antman EM; Cohen M; Grines CL; Goodman S; Kereiakes DJ; Langer A; Mahaffey KW; Nessel CC; Armstrong PW; Avezum A; Aylward P; Becker RC; Biasucci L; Borzak S; Col J; Frey MJ; Fry E; Gulba DC; Guneri S; Gurfinkel E; Harrington R; Hochman JS; Kleiman NS; Leon MB; Lopez-Sendon JL; Pepine CJ; Ruzyllo W; Steinhubl SR; Teirstein PS; Toro-Figueroa L; White H;
    JAMA; 2004 Jul; 292(1):45-54. PubMed ID: 15238590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early ambulation and variability in anticoagulation during elective coronary stenting with a single intravenous bolus of low-dose, low-molecular weight heparin enoxaparin.
    Zalc S; Lemos PA; Esteves A; Ribeiro EE; Horta P; Nicolau JC; Ramires JA; Cohen M; Martinez EE
    J Invasive Cardiol; 2006 Feb; 18(2):45-8. PubMed ID: 16446514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
    Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
    N Engl J Med; 1997 Aug; 337(7):447-52. PubMed ID: 9250846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen.
    Khoobiar S; Mejevoi N; Kaid K; Boiangiu C; Setty S; Tanwir A; Khalid K; Cohen M
    J Thromb Thrombolysis; 2008 Oct; 26(2):85-90. PubMed ID: 18636227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macroscopic thrombus formation on angioplasty equipment following antithrombin therapy with enoxaparin.
    Dana A; Nguyen CM; Cloutier S; Barbeau GR
    Catheter Cardiovasc Interv; 2007 Nov; 70(6):847-53. PubMed ID: 17621651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris.
    Collet JP; Montalescot G; Lison L; Choussat R; Ankri A; Drobinski G; Sotirov I; Thomas D
    Circulation; 2001 Feb; 103(5):658-63. PubMed ID: 11156876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis.
    Sanchez-Pena P; Hulot JS; Urien S; Ankri A; Collet JP; Choussat R; Lechat P; Montalescot G
    Br J Clin Pharmacol; 2005 Oct; 60(4):364-73. PubMed ID: 16187968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?
    Henry TD; Satran D; Knox LL; Iacarella CL; Laxson DD; Antman EM
    Am Heart J; 2001 Oct; 142(4):590-3. PubMed ID: 11579347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of combined use of low molecular weight heparin (enoxaparin, lovenox) and glycoprotein IIb/IIIa receptor antagonist (eptifibatide, integrelin) during nonemergent coronary and peripheral vascular intervention.
    Khosla S; Kunjummen B; Guerrero M; Manda R; Razminia M; Trivedi A; Vidyarthi V; Elbazour M; Ahmed A; Lubell D
    Am J Ther; 2002; 9(6):488-91. PubMed ID: 12424505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of enoxaparin with unfractionated heparins in patients with coronary heart disease in an emergency department in rural South Indian tertiary care teaching hospital.
    Ahmad A; Patel I; Asani H; Jagadeesan M; Parimalakrishnan S; Selvamuthukumaran S
    Indian J Pharmacol; 2015; 47(1):90-4. PubMed ID: 25821318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: results of the STACK-on to ENOXaparin (STACKENOX) study.
    Drouet L; Bal dit Sollier C; Martin J
    Am Heart J; 2009 Aug; 158(2):177-84. PubMed ID: 19619692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable and optimal anticoagulation is achieved with a single dose of intravenous enoxaparin in patients undergoing percutaneous coronary intervention.
    Chen WH; Lau CP; Lau YK; Ng W; Lee PY; Yu CM; Ma E
    J Invasive Cardiol; 2002 Aug; 14(8):439-42. PubMed ID: 12147872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.